Open AccessA randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients
Author(s) -
Amrollah Sharifi,
Mohammad Javad HosseinzadehAttar,
Homayoon Vahedi,
Saharnaz Nedjat
Publication year - 2016
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.187606
Subject(s) - medicine , cathelicidin , vitamin d and neurology , ulcerative colitis , gastroenterology , inflammatory bowel disease , vitamin , interquartile range , placebo , vitamin d deficiency , endocrinology , pathology , disease , receptor , alternative medicine , innate immune system
Inflammatory bowel disease (IBD) is an intestinal chronic inflammatory condition and includes Crohn's disease (CD) and ulcerative colitis (UC). It has been proposed that Vitamin D supplementation may have a beneficial role in IBD.